SCHEMBL19633094

SCHEMBL19633094

Cc1ccc2c(ccn2C(=O)c2cc(N)cn2C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TFPI2 P48307 1/20 0.41
▸ PRKCI P41743 1/20 0.39
▸ HTR2A P28223 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ ROCK1 Q13464 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ TUBB1 Q9H4B7 1/20 0.36
▸ NAMPT P43490 1/20 0.35
▸ FABP4 P15090 2/20 0.35
▸ RXFP1 Q9HBX9 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ LMNA P02545 3/20 0.34
▸ TP53 P04637 1/20 0.34
▸ HDAC3 O15379 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC7 Q8WUI4 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HDAC10 Q969S8 1/20 0.34
▸ HDAC11 Q96DB2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19637042 0.84 TUBB1 (0.55) TFPI2PRKCIHTR2CROCK1TUBB1
Hydrochloric Acid SCHEMBL19614877 0.83 NAMPT (0.40) PRKCIHTR2CNAMPTMAPTLMNA
SCHEMBL14220743 0.80 TFPI2 (0.43) TFPI2THRBTUBB1NAMPTFABP4
SCHEMBL19633093 0.76 THRB (0.43) THRBNAMPTMAPTLMNA
SCHEMBL19753900 0.75 THRB (0.37) TFPI2THRBNAMPTFABP4MAPT
SCHEMBL19633095 0.75 THRB (0.37) TFPI2THRBNAMPTMAPTLMNA
SCHEMBL19633019 0.73 GRM4 (0.37) HTR2CNAMPTMAPTLMNATP53
Hydrochloric Acid SCHEMBL30464353 0.73 GRM4 (0.37) HTR2CNAMPTMAPTLMNATP53
SCHEMBL10837082 0.72 NOTUM (0.59) TFPI2HTR2AHTR2CROCK1THRB
SCHEMBL6901863 0.72 TFPI2 (0.55) TFPI2HTR2AHTR2CROCK1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170333442-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333442-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF CD79B, CLTB, FCGR3B TFPI2 2978/4885PRKCI 3718/4885HTR2A 1610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback